RMC-6291 is an Orally Active and Covalent KRASG12C Inhibitor for Solid Tumor Research
KRAS plays a critical role in regulating cell growth and division. KRAS mutations are common in many types of solid tumors, including lung, colon, and pancreatic cancers, and are associated…